Sign in
4

Changes in Ownership

Immunocore Holdings plc Filed Acc 0001730038-26-000002

CHIEF EXECUTIVE OFFICER sold 11,474 shares at $32.35 ($371,184)

  • CHIEF EXECUTIVE OFFICER acquired 23,817 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jallal Bahija · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-17 Exercise or conversion : show line 1 in the form +23,817 23,817 D
2026-02-18 Sale : show line 2 in the form −11,474 $32.35 $371,184 12,343 D
Open-market sales · 11,474 sh · avg $32.35 · $371,184

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-02-17 Exercise or conversion : show line 3 in the form Restricted Share Units −23,817 71,453 D
2026-02-17 Grant or award : show line 4 in the form Restricted Share Units +88,573 88,573 D
2026-02-17 Grant or award : show line 5 in the form Employee Share Option (Right to Buy) +395,066 395,066 D
Loading xslF345X05/form4-02192026_050209.xml…